Article
Boceprevir with peginterferon alfa-2a-ribavirin is effective for previously treated chronic hepatitis C genotype 1 infection.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association - 1 Jan 2013
Flamm Steven L, Lawitz Eric, Jacobson Ira, Bourlière Marc, Hezode Christophe, Vierling John M, Bacon Bruce R, Niederau Claus, Sherman Morris, Goteti Venkata, Sings Heather L, Barnard Richard O, Howe John A, Pedicone Lisa D, Burroughs Margaret H, Brass Clifford A, Albrecht Janice K, Poordad Fred
Abstract excerpt
BACKGROUND & AIMS: The addition of boceprevir to therapy with peginterferon alfa-2b and ribavirin results in significantly higher rates of sustained virologic response (SVR) in previously treated patients with chronic hepatitis C virus (HCV) genotype-1 infection, compared with peginterferon alfa-2b and ribavirin alone. We assessed SVR with boceprevir plus peginterferon alfa-2a-ribavirin (PEG2a/R) in patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.